• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白变体MacroH2A1是一种BRCA1泛素连接酶底物。

The Histone Variant MacroH2A1 Is a BRCA1 Ubiquitin Ligase Substrate.

作者信息

Kim Beom-Jun, Chan Doug W, Jung Sung Yun, Chen Yue, Qin Jun, Wang Yi

机构信息

Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Cell Rep. 2017 May 30;19(9):1758-1766. doi: 10.1016/j.celrep.2017.05.027.

DOI:10.1016/j.celrep.2017.05.027
PMID:28564596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6507409/
Abstract

The breast- and ovarian-cancer-specific tumor suppressor BRCA1 and its heterodimeric partner BARD1 contain RING domains that implicate them as E3 ubiquitin ligases. Despite extensive efforts, the bona fide substrates of BRCA1/BARD1 remain elusive. Here, we used recombinant GST fused to four UBA domains to enrich ubiquitinated proteins followed by a Lys-ε-Gly-Gly (diGly) antibody to enrich ubiquitinated tryptic peptides. This tandem affinity purification method coupled with mass spectrometry identified 101 putative BRCA1/BARD1 E3 substrates. We identified the histone variant macroH2A1 from the screen and showed that BRCA1/BARD1 ubiquitinates macroH2A1 at lysine 123 in vitro and in vivo. Primary human fibroblasts stably expressing a ubiquitination-deficient macroH2A1 mutant were defective in cellular senescence compared to their wild-type counterpart. Our study demonstrates that BRCA1/BARD1 is a macroH2A1 E3 ligase and implicates a role for macroH2A1 K123 ubiquitination in cellular senescence.

摘要

乳腺癌和卵巢癌特异性肿瘤抑制因子BRCA1及其异源二聚体伴侣BARD1含有RING结构域,这表明它们是E3泛素连接酶。尽管进行了大量研究,但BRCA1/BARD1真正的底物仍然难以确定。在这里,我们使用与四个UBA结构域融合的重组GST来富集泛素化蛋白,随后用赖氨酸-ε-甘氨酸-甘氨酸(二甘氨酸)抗体来富集泛素化的胰蛋白酶肽段。这种串联亲和纯化方法与质谱联用鉴定出了101种可能的BRCA1/BARD1 E3底物。我们从筛选中鉴定出组蛋白变体macroH2A1,并表明BRCA1/BARD1在体外和体内均使macroH2A1的赖氨酸123位点发生泛素化。与野生型相比,稳定表达泛素化缺陷型macroH2A1突变体的原代人成纤维细胞在细胞衰老方面存在缺陷。我们的研究表明BRCA1/BARD1是一种macroH2A1 E3连接酶,并提示macroH2A1 K123位点的泛素化在细胞衰老中发挥作用。

相似文献

1
The Histone Variant MacroH2A1 Is a BRCA1 Ubiquitin Ligase Substrate.组蛋白变体MacroH2A1是一种BRCA1泛素连接酶底物。
Cell Rep. 2017 May 30;19(9):1758-1766. doi: 10.1016/j.celrep.2017.05.027.
2
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.多聚泛素链对BRCA1/BARD1复合物E3连接酶功能的激活作用。
EMBO J. 2002 Dec 16;21(24):6755-62. doi: 10.1093/emboj/cdf691.
3
Mechanisms of BRCA1-BARD1 nucleosome recognition and ubiquitylation.BRCA1-BARD1 核小体识别和泛素化的机制。
Nature. 2021 Aug;596(7872):438-443. doi: 10.1038/s41586-021-03716-8. Epub 2021 Jul 28.
4
BRCA1 is a histone-H2A-specific ubiquitin ligase.乳腺癌1号基因(BRCA1)是一种组蛋白H2A特异性泛素连接酶。
Cell Rep. 2014 Aug 21;8(4):999-1005. doi: 10.1016/j.celrep.2014.07.025. Epub 2014 Aug 14.
5
BARD1 reads H2A lysine 15 ubiquitination to direct homologous recombination.BARD1 读取 H2A 赖氨酸 15 泛素化以指导同源重组。
Nature. 2021 Aug;596(7872):433-437. doi: 10.1038/s41586-021-03776-w. Epub 2021 Jul 28.
6
Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair.BRCA1-BARD1 E3 泛素连接酶活性在同源定向 DNA 修复中的关键作用。
Mol Cell. 2023 Oct 19;83(20):3679-3691.e8. doi: 10.1016/j.molcel.2023.09.015. Epub 2023 Oct 4.
7
The BRCA1/BARD1 ubiquitin ligase and its substrates.BRCA1/BARD1 泛素连接酶及其底物。
Biochem J. 2021 Sep 30;478(18):3467-3483. doi: 10.1042/BCJ20200864.
8
BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.BARD1 对于核小体组蛋白 H2A 的泛素化以及雌激素代谢基因的转录调控是必需的。
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1316-1321. doi: 10.1073/pnas.1715467115. Epub 2018 Jan 24.
9
Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.BRCA1-BARD1 泛素连接酶对雌激素受体 α 稳定性和活性的负反馈环被癌相关型 BARD1 所拮抗。
Int J Biochem Cell Biol. 2010 May;42(5):693-700. doi: 10.1016/j.biocel.2009.12.025. Epub 2010 Jan 11.
10
Protocol for evaluating the E3 ligase activity of BRCA1-BARD1 and its variants by nucleosomal histone ubiquitylation.BRCA1-BARD1 及其变体通过核小体组蛋白泛素化来评估 E3 连接酶活性的方案。
STAR Protoc. 2024 Sep 20;5(3):103294. doi: 10.1016/j.xpro.2024.103294. Epub 2024 Sep 6.

引用本文的文献

1
Chromatin Perturbation Promotes Susceptibility to Hypomethylating Agents.染色质扰动促进对低甲基化剂的敏感性。
bioRxiv. 2025 Jul 31:2025.07.28.666975. doi: 10.1101/2025.07.28.666975.
2
Histone variants: The bricks that fit differently.组蛋白变体:拼接方式各异的“砖块”
J Biol Chem. 2025 Jan;301(1):108048. doi: 10.1016/j.jbc.2024.108048. Epub 2024 Dec 4.
3
Genetic and Epigenetic Interactions Involved in Senescence of Stem Cells.遗传和表观遗传相互作用在干细胞衰老中的作用。
Int J Mol Sci. 2024 Sep 7;25(17):9708. doi: 10.3390/ijms25179708.
4
BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis.BRCA1/BARD1 泛素化 PCNA 以促进未受干扰的条件下的连续 DNA 合成。
Nat Commun. 2024 May 20;15(1):4292. doi: 10.1038/s41467-024-48427-6.
5
macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma.组蛋白 H2A2 拮抗胶质母细胞瘤干性的表观遗传程序。
Nat Commun. 2023 May 27;14(1):3062. doi: 10.1038/s41467-023-38919-2.
6
BRCA1 mediates protein homeostasis through the ubiquitination of PERK and IRE1.BRCA1通过PERK和IRE1的泛素化作用来介导蛋白质稳态。
iScience. 2022 Nov 19;25(12):105626. doi: 10.1016/j.isci.2022.105626. eCollection 2022 Dec 22.
7
DNA Damage Response Regulation by Histone Ubiquitination.组蛋白泛素化调控 DNA 损伤反应
Int J Mol Sci. 2022 Jul 25;23(15):8187. doi: 10.3390/ijms23158187.
8
Histone H2A ubiquitination resulting from Brap loss of function connects multiple aging hallmarks and accelerates neurodegeneration.因Brap功能丧失导致的组蛋白H2A泛素化连接了多个衰老特征并加速神经退行性变。
iScience. 2022 Jun 3;25(7):104519. doi: 10.1016/j.isci.2022.104519. eCollection 2022 Jul 15.
9
BRCA1/BARD1 is a nucleosome reader and writer.BRCA1/BARD1 是核小体读取器和写入器。
Trends Biochem Sci. 2022 Jul;47(7):582-595. doi: 10.1016/j.tibs.2022.03.001. Epub 2022 Mar 26.
10
Histone H2A variants: Diversifying chromatin to ensure genome integrity.组蛋白 H2A 变体:多样化的染色质以确保基因组完整性。
Semin Cell Dev Biol. 2023 Feb 15;135:59-72. doi: 10.1016/j.semcdb.2022.03.011. Epub 2022 Mar 21.

本文引用的文献

1
Human HLTF mediates postreplication repair by its HIRAN domain-dependent replication fork remodelling.人类 HLTF 通过其依赖 HIRAN 结构域的复制叉重塑来介导复制后修复。
Nucleic Acids Res. 2015 Dec 2;43(21):10277-91. doi: 10.1093/nar/gkv896. Epub 2015 Sep 8.
2
MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype.MacroH2A1和ATM在旁分泌衰老及衰老相关分泌表型中发挥相反作用。
Mol Cell. 2015 Sep 3;59(5):719-31. doi: 10.1016/j.molcel.2015.07.011. Epub 2015 Aug 20.
3
Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence.BRCA1基因单倍剂量不足会导致细胞类型特异性的基因组不稳定和早衰。
Nat Commun. 2015 Jun 24;6:7505. doi: 10.1038/ncomms8505.
4
A comprehensive method for detecting ubiquitinated substrates using TR-TUBE.一种使用TR-TUBE检测泛素化底物的综合方法。
Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4630-5. doi: 10.1073/pnas.1422313112. Epub 2015 Mar 31.
5
BRCA1 is a histone-H2A-specific ubiquitin ligase.乳腺癌1号基因(BRCA1)是一种组蛋白H2A特异性泛素连接酶。
Cell Rep. 2014 Aug 21;8(4):999-1005. doi: 10.1016/j.celrep.2014.07.025. Epub 2014 Aug 14.
6
A macrohistone variant links dynamic chromatin compaction to BRCA1-dependent genome maintenance.一种大组蛋白变体将动态染色质压缩与BRCA1依赖的基因组维持联系起来。
Cell Rep. 2014 Aug 21;8(4):1049-62. doi: 10.1016/j.celrep.2014.07.024. Epub 2014 Aug 14.
7
BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss.BRG1 对于由致癌性 RAS 或 BRCA1 缺失诱导的衰老相关异染色质焦点的形成是必需的。
Mol Cell Biol. 2013 May;33(9):1819-29. doi: 10.1128/MCB.01744-12. Epub 2013 Feb 25.
8
Understanding cullin-RING E3 biology through proteomics-based substrate identification.通过基于蛋白质组学的底物鉴定来了解泛素连接酶 E3 的生物学功能。
Mol Cell Proteomics. 2012 Dec;11(12):1541-50. doi: 10.1074/mcp.R112.021154. Epub 2012 Sep 7.
9
Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.定量研究蛋白酶体和去泛素化酶抑制剂抑制后体内蛋白质泛素化变化的方法。
Mol Cell Proteomics. 2012 May;11(5):148-59. doi: 10.1074/mcp.M111.016857. Epub 2012 Apr 14.
10
Systematic and quantitative assessment of the ubiquitin-modified proteome.系统且定量的泛素化蛋白质组学研究。
Mol Cell. 2011 Oct 21;44(2):325-40. doi: 10.1016/j.molcel.2011.08.025. Epub 2011 Sep 8.